AN2 Therapeutics (ANTX) EPS (Basic) (2021 - 2026)
AN2 Therapeutics' (ANTX) quarterly EPS (Basic) came in at -$0.29 in Q1 2026, up 16.91% year-on-year from -$0.25 in Q1 2025, and down 2.14% on a QoQ basis from -$0.29 in Q4 2025.
AN2 Therapeutics (ANTX) EPS (Basic) (2021 - 2026) Analysis & Trends
AN2 Therapeutics (ANTX) has 6 years of EPS (Basic) data on file, last reported at -$0.29 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 16.91% year-over-year to -$0.29 in Q1 2026; TTM through Mar 2026 was -$1.01, a 32.77% increase from a year earlier, with the FY2025 full-year figure at -$1.16, up 32.34% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.29, down from -$0.29 in the prior quarter.
- Over the last five years, EPS (Basic) for ANTX reached as high as -$0.21 in Q2 2025 and fell as low as -$2.98 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.65 across 5 years, with a median of -$0.53 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 82.53% in 2022 and fell as far as 177.92% in 2022.
- Year by year, EPS (Basic) stood at -$0.77 in 2022, then gained by 7.25% to -$0.72 in 2023, then soared by 64.78% to -$0.25 in 2024, then declined by 14.31% to -$0.29 in 2025, then slipped by 2.14% to -$0.29 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.29 in Q1 2026, -$0.29 in Q4 2025, and -$0.31 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | 0.00 |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn | 7.59 |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 1.55 |
| 10 | AN2 Therapeutics | 168.37 Mn | 168.37 Mn | - | -0.29 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.29 |
| Dec 31, 2025 | -0.29 |
| Sep 30, 2025 | -0.31 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -0.35 |
| Dec 31, 2024 | -0.25 |
| Sep 30, 2024 | -0.43 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.56 |
| Dec 31, 2023 | -0.72 |
| Sep 30, 2023 | -0.65 |
| Jun 30, 2023 | -0.81 |
| Mar 31, 2023 | -0.79 |
| Dec 31, 2022 | -0.77 |
| Sep 30, 2022 | -0.59 |
| Jun 30, 2022 | -0.53 |
| Mar 31, 2022 | -2.98 |
| Dec 31, 2021 | -3.59 |
| Sep 30, 2021 | -3.35 |
| Jun 30, 2021 | -2.62 |